Lv1
30 积分 2023-05-30 加入
Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer
13天前
已完结
Histopathology-based Artificial Intelligence Algorithms for the Prediction of Prostate Cancer Metastasis After Radical Prostatectomy
13天前
已完结
Cancer burden and control in China: landscape, trends and challenges
17天前
已完结
Assessing the attitudes to prostate cancer treatment among European male patients
1个月前
已完结
Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients
1个月前
已完结
Exploring the biology of metastatic hormone-sensitive prostate cancer: on the road to precision medicine
1个月前
已完结
Controversies in metastatic hormone‐sensitive prostate cancer
1个月前
已完结
Combination Therapies in Locally Advanced and Metastatic Hormone-sensitive Prostate Cancer
1个月前
已完结
ARCHES 5-year Survival with Enzalutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients
1个月前
已完结
Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk and locally advanced prostate cancer: a multicenter, open-label, single-arm, phase II trial
2个月前
已完结
皖公网安备34019202002308
